SS, Z., & VW, Z. (2021). Spotlight on Mobocertinib (TAK-788) in NSCLC with EGFR Exon 20 Insertion Mutations. Dove Medical Press.
Cita Chicago Style (17a ed.)SS, Zhang, y Zhu VW. Spotlight on Mobocertinib (TAK-788) in NSCLC with EGFR Exon 20 Insertion Mutations. Dove Medical Press, 2021.
Cita MLA (8a ed.)SS, Zhang, y Zhu VW. Spotlight on Mobocertinib (TAK-788) in NSCLC with EGFR Exon 20 Insertion Mutations. Dove Medical Press, 2021.
Precaución: Estas citas no son 100% exactas.